Dark

VKTX
Viking Therapeutics, Inc
stock NASDAQ

At Close

Feb 5, 2026 3:59:53 PM EST

26.29USD-11.062%(-3.27)5,729,506

0.00Bid 0.00Ask 0.00Spread

Pre-market

Feb 5, 2026 9:27:30 AM EST

28.20USD-4.601%(-1.36)24,186

After-hours

Feb 5, 2026 4:58:30 PM EST

26.00USD-1.103%(-0.29)23,219

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

2.97B

CEO

Brian Lian

Headquarters

San Diego, California, USA

Industry

Biotechnology

Next Earnings

Feb 11, 2026 (5d)

REPH RARE XLV

VKTX Stats

Avg. Vol. 10 Day

2,682,442

Avg. Vol. 30 Day

3,047,624

Employees

Market Cap

2,970,595,120

Shares Out.

113,036,344

On/Off Exchange

50%/50%

6 Month Beta

1.73

1 Year Beta

1.42

2 Year Beta

1.63

3 Year Beta

1.47

52 Week Low

18.92

52 Week High

43.15

SMA50

34.15

SMA200

31.21

1 Week

-13.10%

1 Month

-18.23%

3 Month

-27.94%

6 Month

-22.77%

1 Year

-21.55%

2 Year

+6.57%

5 Year

+171.77%

Profile

novel therapeutics for metabolic and endocrine disorders.

VKTX Stock Summary

Viking Therapeutics, Inc (NASDAQ:VKTX) stock price today is $26.29, and today's volume is 5,729,506. VKTX is down -11.062% today. The 30 day average volume is 3,047,624. VKTX market cap is 2.97B with 113,036,344 shares outstanding.